Improving Palliative Care Access Through Technology

Status Suspended

Clinical Trial Summary

This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.

Clinical Trial Description

Almost 1.8 million older Americans live in nursing homes (NH), with estimates that this number will grow to more than 3 million by 2050. NHs are increasingly becoming the place of care and site of death for frail older adults dying from multiple chronic illnesses. Unfortunately, most residents die without the benefit of palliative care (PC) or with palliation delayed until the last days of life. Unfortunately, hospice services are often the only formal end of life care service available in NHs, and access to hospice enrollment is complicated by financial implications for both NHs and residents. Telehealth, or remote monitoring of patients through information and communication technologies, is an effective mechanism for addressing the increased demand on health services and has much to offer to people living with and dying from advanced illness. Moreover, numerous studies have demonstrated positive benefits of using telehealth in the NH to improve access to consultants (e.g., neurology, dermatology, psychiatry). Little is known, however, about the effect of using Telehealth on improving access to PC specialists in the NH setting. The proposed ImPAcTT intervention employs a secure communications platform that permits multi-person live video, audio, and text message consultations; real-time document sharing and documentation for advanced care planning discussions; and remote virtual assessment capabilities. The investigator will conduct a pilot implementation trial of ImPAcTT in 3 study nursing homes to evaluate our ability to safely recruit and retain study participants, collect appropriate and accurate data, and determine preliminary estimates of an effect size of the intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04969484
Study type	Interventional
Source	University of Utah
Contact
Status	Suspended
Phase	N/A
Start date	February 19, 2018
Completion date	June 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04673760` - The PROAKTIV Study	N/A
Completed	`NCT03520023` - Critical Care and Palliative Care Medicine Together in the ICU	N/A
Completed	`NCT01990742` - Improving Palliative Care Through Teamwork	N/A
Not yet recruiting	`NCT05434208` - Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)	N/A
Not yet recruiting	`NCT03267706` - Introducing the Palliative Care Comprehensive Tool in Family Medicine	N/A
Completed	`NCT02845817` - Requests for Euthanasia and Assisted Suicide	N/A
Recruiting	`NCT02778347` - Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs	N/A
Completed	`NCT01934413` - Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Recruiting	`NCT01170000` - Timely End-of-Life Communication to Parents of Children With Brain Tumors	N/A
Recruiting	`NCT04052074` - Complementary Therapy in Home Palliative Care Patients and Their Caregivers	N/A
Recruiting	`NCT05935540` - ACP-Family Programme for Palliative Care Patients and Their Family Member	N/A
Active, not recruiting	`NCT02689375` - A Prospective, Open Label, Pilot Study of Patient OutcoMes Following Successful TriAl of High Frequency SpInal CorD Stimulation at 10kHz (HF10™) Leading to Permanent Implant Compared to Trial Failure and Standard CarE for the TreatmeNt of Persistent Low BACK Pain of Neuropathic Origin	N/A
Recruiting	`NCT05520281` - Short-term Psychodynamic Psychotherapy in Serious Physical Illness	N/A
Completed	`NCT06140004` - Home-Based Palliative Care Impact on Providers
Completed	`NCT04333719` - Prevalence of Deep Sedation in Terminal Palliative Phase
Recruiting	`NCT03286127` - Palliative Outcome Evaluation Muenster I
Completed	`NCT06211816` - Efficacy of End-of-life Communication Strategies on Nurses in the Intensive Care Unit	N/A
Completed	`NCT04857060` - Palliative Care Educator	N/A
Completed	`NCT04491110` - Intervention to Improve Quality of Sleep of Palliative Patient Carers in the Community: Clinical Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Improving Palliative Care Access Through Technology — ImPAcTT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms